{
    "title": "Cytochrome P450 2C19 Genotypes and Clopidogrel in Patients With Ischemic Stroke: A Nonrandomized Clinical Trial",
    "pmid": "40184070",
    "pmcid": "PMC11971672",
    "study_parameters": [
        {
            "Study Parameters ID": 1453096140,
            "Variant Annotation ID": 1453096120,
            "Study Type": "clinical trial",
            "Study Cases": 2910.0,
            "Study Controls": null,
            "Characteristics": "PLATELET trial, Recurrent stroke",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": null,
            "Allele Of Frequency In Cases": null,
            "Frequency In Controls": null,
            "Allele Of Frequency In Controls": null,
            "P Value": "= 0.047",
            "Ratio Stat Type": "HR",
            "Ratio Stat": 0.56,
            "Confidence Interval Start": 0.32,
            "Confidence Interval Stop": 1.0,
            "Biogeographical Groups": "Unknown",
            "Variant Annotation ID_norm": "1453096120"
        },
        {
            "Study Parameters ID": 1453096116,
            "Variant Annotation ID": 1453096120,
            "Study Type": "clinical trial",
            "Study Cases": 2910.0,
            "Study Controls": null,
            "Characteristics": "PLATELET trial, composite outcome (recurrent stroke, myocardial infarction, and all-cause mortality at 180 days)",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": null,
            "Allele Of Frequency In Cases": null,
            "Frequency In Controls": null,
            "Allele Of Frequency In Controls": null,
            "P Value": "= 0.048",
            "Ratio Stat Type": "HR",
            "Ratio Stat": 0.58,
            "Confidence Interval Start": 0.34,
            "Confidence Interval Stop": 1.0,
            "Biogeographical Groups": "Unknown",
            "Variant Annotation ID_norm": "1453096120"
        }
    ],
    "var_drug_ann": [],
    "var_pheno_ann": [
        {
            "Variant Annotation ID": 1453096120,
            "Variant/Haplotypes": "CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17",
            "Gene": "CYP2C19",
            "Drug(s)": "clopidogrel",
            "PMID": 40184070,
            "Phenotype Category": "Efficacy",
            "Significance": "yes",
            "Notes": "Overall, 49 of 1785 LOF allele carriers (2.7%) and 18 of 1125 LOF allele noncarriers (1.6%) experienced cardiovascular events, defined as a composite of recurrent stroke, myocardial infarction, and all-cause mortality at 180 days...The primary outcome of composite cardiovascular events occurred significantly more in the LOF allele carrier group (49 of 1785 [2.7%]) compared with the noncarrier group (18 of 1125 [1.6%]) (HR, 0.58; 95% CI, 0.34-1.00; P = .048 for log-rank test).",
            "Sentence": "CYP2C19 *1/*2 + *1/*3 + *2/*17 + *3/*17 + *2/*2 + *2/*3 + *3/*3 (assigned as intermediate metabolizer and poor metabolizer phenotype) is associated with increased likelihood of Stroke, Myocardial Infarction or Death when treated with clopidogrel in people with Stroke as compared to CYP2C19 *1/*1 + *1/*17 + *17/*17 (assigned as normal metabolizer phenotype) .",
            "Alleles": "*1/*2 + *1/*3 + *2/*17 + *3/*17 + *2/*2 + *2/*3 + *3/*3",
            "Specialty Population": null,
            "Metabolizer types": "intermediate metabolizer and poor metabolizer",
            "isPlural": "Is",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "increased",
            "Side effect/efficacy/other": "likelihood of",
            "Phenotype": "Efficacy:Stroke, Efficacy:Myocardial Infarction, Efficacy:Death",
            "Multiple phenotypes And/or": "or",
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": null,
            "Population types": "in people with",
            "Population Phenotypes or diseases": "Other:Stroke",
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": "*1/*1 + *1/*17 + *17/*17",
            "Comparison Metabolizer types": "normal metabolizer",
            "PMID_norm": "40184070",
            "Variant Annotation ID_norm": "1453096120"
        }
    ],
    "var_fa_ann": []
}